← RESOURCES
[ MHRA · UK DRUG & DEVICE ALERTS ]
What the UK regulator is recalling, in real time.
The MHRA publishes Class 1–4 medicines recalls, field safety notices, and device safety information as its formal signal that a product is defective or unsafe — the UK counterpart to an FDA recall. SPEQ tracks each recent alert with its type, date, and a link to the full notice.
104
Alerts tracked
28 Jul 2026
Most recent
4
Alert types
Drug Safety Update · 50Medicines recall/notification · 25Field safety notice · 22MHRA Safety Roundup · 4
28 Jul 2026Field safety notice
Field Safety Notices: 20 to 24 July 2026
View details →
23 Jul 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
View details →
21 Jul 2026Field safety notice
Field Safety Notices: 13 to 17 July 2026
View details →
21 Jul 2026Drug Safety Update
Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension
View details →
20 Jul 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
View details →
15 Jul 2026Drug Safety Update
Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism
View details →
14 Jul 2026Field safety notice
Field Safety Notices: 6 to 10 July 2026
View details →
13 Jul 2026Medicines recall/notification
Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34
View details →
9 Jul 2026Medicines recall/notification
Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33
View details →
7 Jul 2026Medicines recall/notification
UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
View details →
7 Jul 2026Field safety notice
Field Safety Notices: 29 June to 03 July 2026
View details →
30 Jun 2026Field safety notice
Field Safety Notices: 22 to 26 June 2026
View details →
30 Jun 2026Medicines recall/notification
Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
View details →
30 Jun 2026MHRA Safety Roundup
MHRA Safety Roundup: June 2026
View details →
29 Jun 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30
View details →
23 Jun 2026Field safety notice
Field Safety Notices: 15 to 19 June 2026
View details →
16 Jun 2026Drug Safety Update
ACE-inhibitors: Be aware of the distinction between bradykinin- and histamine-mediated angioedema, as treatment strategies differ significantly
View details →
16 Jun 2026Medicines recall/notification
Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29
View details →
15 Jun 2026Field safety notice
Field Safety Notices: 8 -12 June 2026
View details →
8 Jun 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28
View details →
8 Jun 2026Field safety notice
Field Safety Notices: 1-5 June 2026
View details →
5 Jun 2026Field safety notice
Field Safety Notices: 18 -22 May 2026
View details →
4 Jun 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27
View details →
2 Jun 2026Medicines recall/notification
Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators, EL(26)A/26
View details →
2 Jun 2026Field safety notice
Field Safety Notices: 25 to 29 May 2026
View details →
28 May 2026Medicines recall/notification
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
View details →
28 May 2026MHRA Safety Roundup
MHRA Safety Roundup: May 2026
View details →
27 May 2026
Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)
View details →
22 May 2026
Kimal Procedure Packs containing recalled components: Namic Angiographic Syringe with the risk of syringe disconnection; Namic Manifolds with the risk of foreign particulates. Important guidance for use in urgent procedures where there are no alternatives. (DSI/2026/002)
View details →
22 May 2026Field safety notice
Field Safety Notices: 11 to 15 May 2026
View details →
20 May 2026
Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)
View details →
20 May 2026Drug Safety Update
Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision
View details →
14 May 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24
View details →
12 May 2026Field safety notice
Field Safety Notices: 4 to 8 May 2026
View details →
12 May 2026Field safety notice
Field Safety Notices: 27 April to 1 May 2026
View details →
11 May 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23
View details →
11 May 2026Drug Safety Update
Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction
View details →
6 May 2026Field safety notice
Field Safety Notices: 1 May 2026
View details →
30 Apr 2026Field safety notice
Field Safety Notices: 20 to 24 April 2026
View details →
30 Apr 2026Drug Safety Update
Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse
View details →
29 Apr 2026MHRA Safety Roundup
MHRA Safety Roundup: April 2026
View details →
28 Apr 2026Medicines recall/notification
Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22
View details →
24 Apr 2026Medicines recall/notification
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
View details →
23 Apr 2026Field safety notice
Field Safety Notices: 13 to 17 April 2026
View details →
22 Apr 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
View details →
20 Apr 2026Medicines recall/notification
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19
View details →
13 Apr 2026Field safety notice
Field Safety Notices: 6 to 10 April 2026
View details →
8 Apr 2026Field safety notice
Field Safety Notices: 30 March - 3 April 2026
View details →
31 Mar 2026Field safety notice
Field Safety Notices: 23-27 March 2026
View details →
31 Mar 2026MHRA Safety Roundup
MHRA Safety Roundup: March 2026
View details →
30 Mar 2026Medicines recall/notification
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18
View details →
26 Mar 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17
View details →
26 Mar 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets , EL(26)A/16
View details →
24 Mar 2026Field safety notice
Field Safety Notices: 16 - 20 March 2026
View details →
23 Mar 2026Medicines recall/notification
Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15
View details →
20 Mar 2026Field safety notice
Field Safety Notices: 9 - 13 March 2026
View details →
17 Mar 2026Medicines recall/notification
Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion, EL(26)A/14
View details →
12 Mar 2026Medicines recall/notification
Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12
View details →
12 Mar 2026Medicines recall/notification
Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml), EL(26)A/13
View details →
2 Mar 2026Field safety notice
Field Safety Notices: 02 to 06 March 2026
View details →
Source: MHRA Drug & Device Alerts and Drug Safety Update, from the official gov.uk feeds, refreshed daily. Alerts are MHRA records reproduced as published — SPEQ adds no interpretation. The archive builds forward from the first scan.